by Blood plasma derivatives are by-products extracted and manufactured from blood plasma through complex fractionation processes. Key blood plasma derivatives include immunoglobulins, albumin, coagulation factors, and protease inhibitors that help treat diseases and medical conditions. Growing aging population, coupled with rising incidences of immune deficiencies, bleeding disorders, and neurological diseases has significantly increased the demand for blood plasma derivatives. For instance, immunoglobulins derived from blood plasma are widely used for treating primary immunodeficiency disorders and neurological infections.
The global Blood Plasma Derivatives Market is estimated to be valued at US$ 44.33 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends
One of the key trends in the blood plasma derivatives market is the increasing adoption of immunoglobulins. Immunoglobulins help in boosting the immune system and treat various immune disorders by replacing deficient antibodies. Intravenous immunoglobulin (IVIg) therapy derived from blood plasma is increasingly being used for treating chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN). Furthermore, subcutaneous immunoglobulin (SCIg) therapy is gaining traction over IVIg therapy as it allows for home therapy with fewer side effects. Growing burden of immune deficiencies worldwide has prompted companies to focus on increasing immunoglobulin production capacity through expanding fractionation facilities as well as improving collection and purification processes. This is expected to positively impact the immunoglobulin segment growth over the forecast period.
Porter’s Analysis
Threat of new entrants: The blood plasma derivatives market requires huge investments for collection facilities and fractionation plants which acts as a barrier for new players. Strict regulations regarding purity of derivatives also restrict new entrants.
Bargaining power of suppliers: The key raw material for this industry is human blood plasma which is collected from donors or professional donors. Abundant supply of plasma globally reduces the bargaining power of suppliers.
Bargaining power of buyers: The buyers in this industry are pharmaceutical companies, hospitals and research organizations. Large buyers can negotiate prices down but the criticality of products in healthcare increases their dependency on vendors.
Threat of new substitutes: There are no effective substitutes for plasma derivatives currently. However, ongoing research on recombinant and synthetic alternatives can pose a threat in long run if commercialized successfully.
Competitive rivalry: The market is dominated by few global players. Intense competition exists in terms of expanding collection networks, production facilities and launching new products. Players compete on quality standards and expanding portfolio of innovative products.
Key Takeaways
The global Blood Plasma Derivatives Market Size is expected to witness high growth.
Regional analysis: North America currently dominating the market due to presence of major players and rising demand for immunoglobulins and coagulation factors. Europe is the second largest market driven by growth in Germany, Italy and France. However, Asia Pacific is anticipated to be the fastest growing region supported by increasing healthcare investments and expanding plasma collection infrastructure in China and India.
Key players operating in the blood plasma derivatives market are Iron Mountain, ARC, Access, Shred-it, Restore plc, Cintas, Proshred, National Document Shredding Service, Shred Station, Red Dog Shred, Shred-X, Secured Document Shredding, Shred Works, Guardian Data Destruction, EndoShred, Mobile Shred, ShredQuick, ProShred Chicago, Shreds Unlimited. Key players are focused on new product launches, expanding their operational footprints especially in emerging economies and collaborating with blood collection centers and hospitals to strengthen their supply chain.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
